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Abstract
Background: Plasmodium falciparum, the causative agent of severe human malaria, has evolved to become resistant 
to previously successful antimalarial chemotherapies, most notably chloroquine and the antifolates. The prevalence of 
resistant strains has necessitated the discovery and development of new chemical entities with novel modes-of-action. 
Although much effort has been invested in the creation of analogues based on existing drugs and the screening of 
chemical and natural compound libraries, a crucial shortcoming in current Plasmodial drug discovery efforts remains 
the lack of an extensive set of novel, validated drug targets. A requirement of these targets (or the pathways in which 
they function) is that they prove essential for parasite survival. The polyamine biosynthetic pathway, responsible for the 
metabolism of highly abundant amines crucial for parasite growth, proliferation and differentiation, is currently under 
investigation as an antimalarial target. Chemotherapeutic strategies targeting this pathway have been successfully 
utilized for the treatment of Trypanosomes causing West African sleeping sickness. In order to further evaluate 
polyamine depletion as possible antimalarial intervention, the consequences of inhibiting P. falciparum spermidine 
synthase (PfSpdSyn) were examined on a morphological, transcriptomic, proteomic and metabolic level.
Results: Morphological analysis of P. falciparum 3D7 following application of the PfSpdSyn inhibitor cyclohexylamine 
confirmed that parasite development was completely arrested at the early trophozoite stage. This is in contrast to 
untreated parasites which progressed to late trophozoites at comparable time points. Global gene expression analyses 
confirmed a transcriptional arrest in the parasite. Several of the differentially expressed genes mapped to the 
polyamine biosynthetic and associated metabolic pathways. Differential expression of corresponding parasite proteins 
involved in polyamine biosynthesis was also observed. Most notably, uridine phosphorylase, adenosine deaminase, 
lysine decarboxylase (LDC) and S-adenosylmethionine synthetase were differentially expressed at the transcript and/or 
protein level. Several genes in associated metabolic pathways (purine metabolism and various methyltransferases) 
were also affected. The specific nature of the perturbation was additionally reflected by changes in polyamine 
metabolite levels.
Conclusions: This study details the malaria parasite's response to PfSpdSyn inhibition on the transcriptomic, 
proteomic and metabolic levels. The results corroborate and significantly expand previous functional genomics studies 
relating to polyamine depletion in this parasite. Moreover, they confirm the role of transcriptional regulation in P. 
falciparum, particularly in this pathway. The findings promote this essential pathway as a target for antimalarial 
chemotherapeutic intervention strategies.Becker et al. BMC Genomics 2010, 11:235
http://www.biomedcentral.com/1471-2164/11/235
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Background
At present, antimalarial drug resistance is a critical threat
and the need for compounds with novel modes-of-action
is imperative. Malaria pathogenesis is exhibited during
the asexual erythrocytic cycle of Plasmodium falciparum
in the human host and a variety of parasite processes and
diverse targets are potentially available to inhibit parasite
proliferation. One of these targets is the biosynthesis of
polyamines - essential and ubiquitous small, aliphatic
compounds containing two or more amino groups, which
in eukaryotes mainly include putrescine, spermidine and
spermine [1]. A fourth polyamine, cadaverine, is a struc-
tural analogue of putrescine with functions similar to the
other polyamines though better characterized in prokary-
otes [2]. At physiological pH, these polycations interact
electrostatically with various anionic macromolecules
such as DNA, RNA, ATP, phospholipids and proteins
[1,3]. These interactions can alter DNA conformation,
regulate replication and transcription, strengthen mem-
branes, regulate ion channels and protect DNA and phos-
pholipids from oxidative stress [1,3-6].
Ornithine decarboxylase (ODC) and S-adenosylmethi-
onine decarboxylase (AdoMetDC) usually regulate
polyamine metabolism and inhibitors against these
enzymes are being applied in diverse therapies ranging
from tumour suppressors to the treatment of West Afri-
can sleeping sickness (Trypanosoma brucei gambiense),
validating polyamine metabolism as a target for drug
intervention in these protozoan parasites [1]. In P. falci-
parum  AdoMetDC and ODC are encoded by a single
polypeptide to form a unique bifunctional protein (PfA-
d o M e t D C / O D C )  [ 7 ] .  T h i s  e n z y m e  h a s  b e e n  t h e  m a i n
focus of studies assessing polyamine metabolism as a
drug target in the parasite. However, traditional inhibi-
tors of the polyamine pathway aimed at these proteins
have cytostatic effects with curative rates only achieved in
combination with polyamine analogues in murine
malaria models [8]. A previous study focused on PfA-
doMetDC/ODC indicated that polyamine depletion
resulted in transcriptional arrest [9], which manifested as
a halt in the parasite's intraerythrocytic developmental
cycle (IDC). Therefore, polyamines appear to be essential
molecules for parasite survival and promising targets for
antimalarial therapeutic intervention [10].
Spermidine is synthesized from putrescine and decar-
boxylated S-adenosylmethionine (dcAdoMet) through
the aminopropyltransferase action of spermidine syn-
thase (SpdSyn) [11]. In P. falciparum, this protein has the
additional and unique function of being responsible for
the low level production of spermine [12,13]. The relative
paucity of polyamine studies focused on PfSpdSyn may
belie the importance and essential nature of this enzyme,
reflected by the need for spermidine in the synthesis of
hypusine, eukaryotic initiation factor 5A and its involve-
ment in P. falciparum DNA polymerase and topoi-
somerase I and II [14]. In addition, the lack of polyamine
interconversion in P. falciparum implicates the flux
through PfSpdSyn as the determinant of spermidine lev-
els [10,15]. In support of the latter, inhibition of PfSpdSyn
activity with either substrate or transition state analogues
has been shown to totally block P. falciparum schizogony
due to depletion of spermidine [16]. This contrasts with
other cell lines in which growth rates were only moder-
ately affected, due to the maintenance of cellular
polyamine levels by the interconversion pathway [17].
Evidence for the rescue of PfSpdSyn inhibition by exoge-
nous polyamines is contradictory and seems to be depen-
dent on the inhibitor used: reversibility was found with
the putrescine analogue dicyclohexylamine [16] but not
with the more potent inhibitors, trans-4-methylcyclohex-
ylamine (4 MCHA) or 5-amino-1-pentene (APE) [12].
The modes of gene regulation in P. falciparum is cur-
rently controversial, with evidence supporting the domi-
nant role of post-transcriptional control on the one hand
[18-21] and evidence mounting for the presence of tran-
scriptional control, particularly in response to external
perturbations on the parasite, on the other [9,22-27]. A
recent functional genomics study of co-inhibited PfA-
doMetDC/ODC demonstrated that perturbation-specific
compensatory transcriptional responses are induced
within the parasite to alleviate the effects of polyamine
depletion [9], similar to a previous study of ODC-inhib-
ited malaria parasites [28]. In the investigation presented
here, these two studies were extended to analyze the
effect of inhibition of PfSpdSyn. Remarkably, unique
inhibitor-specific effects were detected on several levels
in this study. Moreover, perturbation-specific effects
relating to polyamine depletion, as reported in the previ-
ous studies, were confirmed, thus corroborating the role
of transcriptional regulation in polyamine metabolism of
P. falciparum.
Results
Morphological Study
A number of compounds have been shown to inhibit
s p e r m i d i n e  s y n t h a s e  a c t i v i t y  i n  P. falciparum [12,16].
Some of these drugs include dicyclohexylamine, agma-
tine, 1,7-diaminoheptane, 4 MCHA, APE, (S, R)-dcA-
doMet, 1-aminoxy-3-aminopropane (APA) and
cyclohexylamine. Of these, only dicyclohexylamine and
cyclohexylamine are commercially available, with cyclo-
hexylamine being more potent and inhibiting P. falci-
parum growth with an IC50 of 198 μM compared to 342
μM, for dicyclohexylamine [12]. The potency of cyclo-
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hexylamine was also reflected in its inhibition of recom-
binantly expressed PfSpdSyn (IC50 of 19.7 μM, [12]). This
motivated the use of cyclohexylamine to obtain PfSpdSyn
inhibition in in vitro P. falciparum cultures and investi-
gate the resultant effects on parasite morphology, tran-
scriptome, proteome and selected polyamine
metabolites.
A morphological study was performed on PfSpdSyn
inhibited parasites to ensure complete growth arrest at
the drug concentration used (2 mM cyclohexylamine)
and to determine sampling times for subsequent tran-
scriptome, proteome and metabolite analyses. Drug
treatment was initiated during parasite invasion. Treated
parasites were arrested in the early trophozoite stage,
while untreated parasites had matured from early to mid/
late trophozoites at 30 hours post invasion (hpi) (Figure
1A). There were no morphologically detectable differ-
ences between treated and untreated parasites in the ear-
lier stages (ring stage parasites, results not shown),
limiting the possibility of off-target effects of the drug
treatment prior to PfSpdSyn inhibition. These results
correlate with findings indicating a stage-specific expres-
sion of PfSpdSyn with maximum accumulation of tran-
script and protein in trophozoites at 18 hpi [12] (ranging
from 10 - 40 hpi, Malaria IDC Strain Comparison Data-
base [29]), and a morphological visible difference in para-
sites treated with cyclohexylamine only after PfSpdSyn is
produced (Figure 1A). Based on these results, sampling
times for subsequent transcriptome and proteome analy-
ses were chosen at early (18 hpi), mid (25 hpi) and late (30
hpi) trophozoite stages, thereby spanning the period in
which PfSpdSyn is maximally expressed and during
which parasite growth arrest is observed. Metabolite
analyses were performed at 25 hpi.
Figure 1 Morphological analysis of Plasmodium falciparum following inhibition of PfSpdSyn with cyclohexylamine. (A) Parasites treated with 
cyclohexylamine at invasion were arrested in the early trophozoite stage, correlating close to the time of maximal expression of this transcript in the 
intaerythrocytic developmental cycle (IDC). Untreated parasites matured through mid- into late trophozoites at comparable time points. Arrows indi-
cate the Pearson correlation (r) between samples. In its 48 h lifecycle, the expression of PfSpdSyn is maximally expressed at 18 hours post-invasion 
(hpi) in a window of expression from 10-40 hpi. (B) Pearson correlations of untreated and treated samples, showing poor correlations of untreated 
samples to their treated counterparts at later time points (25 and 30 hpi). The approximate time of arrest (between 10 and 18 hpi) is indicated by the 
highest correlations to the untreated samples at 18 hpi.
Untreated Treated
18 
hpi
25 
hpi
30 
hpi
Invasion
(T=0)
UT18 T18
UT25
UT30
T25
T30
UT18 UT25 UT30
T18 0.62 0.33 0.09
T25 0.66 0.50 0.24
T30 0.71 0.54 0.27
0.82 0.26
0.65 0.86
0.88 0.66
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Transcriptional profiling of cyclohexylamine-treated P. 
falciparum
Transcriptome analyses of cyclohexylamine-treated com-
pared to untreated parasites employed a reference design
[30] for hybridization to an Operon oligonucleotide array,
interrogating 7797 70-mer oligonucleotides which repre-
sent 4585 unique genes. RNA was extracted from several
untreated, unsynchronized P. falciparum 3D7 cultures
and cDNA synthesized for construction of a universal ref-
erence RNA (URR) pool resulting in 86% coverage,
according to the method of Novoradovskaya (2004) [31].
Technical and biological variation between hybridisations
was estimated by Pearson correlations between the indi-
vidual slides. 5506 datapoints (spots) passing the normal-
isation filters across all arrays (18 datasets) were utilised
for this purpose. Technical variation was calculated as
0.90 ± 0.04 across all replicates. Biological variation was
calculated as 0.85 ± 0.10 across all biological replicates.
All technical and biological correlations are given in full
in Additional file 1: Table S1. Pearson correlations (r) of
the relative expression values of the untreated (UT18,
UT25 or UT30) and treated (T18, T25 or T30) samples com-
pared to the reference pool utilised 6823 spots (six col-
lated datasets) in the analyses. The correlations indicated
transcriptional arrest in the parasite following cyclohexy-
lamine treatment (Figure 1B). This is evident from Pear-
son correlations between treated samples, where T18 vs
T25 = 0.86, T18 vs T30 = 0.82 and T25 vs T30 = 0.88, indicat-
ing that after cyclohexylamine treatment, parasites were
in comparable transcriptional states (Figure 1A). In con-
trast, in untreated samples, where no arrest was observed
at a transcriptional or morphological level, correlations
between time points were significantly lower (e.g. UT18 vs
UT30 = 0.26, Figure 1B). Parasite arrest was estimated
c l o s e  t o  1 8  h p i ,  a s  c a n  b e  g a u g e d  f r o m  c o r r e l a t i o n s
between untreated and treated samples (UT18 vs T18 =
0.62; UT18 vs T25 = 0.66 and UT18 vs T30 = 0.71), which
indicate the approximate time of transcriptional arrest
(close to but not exactly at 18 hpi) leading to the observed
cytostasis (Figure 1B). Additionally, this cytostasis corre-
lates well with the expression time of PfSpdSyn spanning
10-40 hpi and reaching maximal expression at 18 hpi
(Malaria IDC Strain Comparison Database [29]). The
comparison of the cytostatically arrested treated para-
sites to untreated parasites at 18 hpi (UT18) is therefore
essential to identify differences in the transcriptomes due
to drug treatment. Parallel time point comparisons indi-
cated lower correlation values (UT30 to T30 at 0.27) indi-
cating the presence of cell cycle differences between these
populations and negating the use of direct time point
comparisons. These results are in strong agreement with
those obtained by van Brummelen (2009) [9], where the
combination of two cytostatic drugs that target the
polyamine pathway also resulted in a global transcrip-
tional arrest after polyamine depletion. Subsequently, for
analysis of significantly affected transcripts, all samples
w e r e  c o m p a r ed  t o  UT 18, thereby following a reference
point strategy similar to previous reports [9,26], such that
drug-specific events were observed and not only cell
cycle/stage differences.
Following analysis of differentially expressed tran-
scripts with the LIMMA package in R, it emerged that a
total of 706 unique genes (Additional file 2: Table S2)
were differentially regulated (across all time points) at
least two-fold when applying a false discovery rate cutoff
of 5% (significance of p = 0.05). This amounted to 26.4%
of the total unique PlasmoDB identities passing the data
normalization and quality filter (2673 in total) on the
array and included 387 downregulated and 319 upregu-
lated transcripts. The largest number of transcripts dif-
ferentially expressed occurred at T18  (502 in total),
declining to 472 at T25 and 221 at T30 (Additional file 2:
Table S2). Several of these transcripts were differentially
expressed at multiple time points.
The transcriptome data was validated by examining rel-
ative expression of five transcripts functioning in the
polyamine/methionine biosynthetic pathway with quan-
titative real-time PCR (RT-qPCR) analyses. Primers were
designed to specifically amplify adenosine deaminase
(PF10_0289), LDC (PFD0285c), uridine phosphorylase
(PFE0660c), phosphoethanolamine N-methyltransferase
(MAL13P1.214) and spermidine synthase (PF11_0301).
Eukaryotic translation initiation factor 3 subunit 10
(PFL0625c) was used as endogenous control, since its
transcript was not affected by the drug perturbation
throughout the time period analyzed, as deduced from
array data (at p < 0.05) and the Malaria IDC Strain Com-
parison Database [29]. RT-qPCR data was in strong
agreement with that obtained from array analyses (Table
1), as indicated by a Pearson correlation value of 0.88 for
the two datasets. RT-qPCR analyses confirmed the direc-
tion of differential regulation (up or down) as well as
where transcripts were deemed to be unchanged by the
perturbation (e.g. spermidine synthase). Downregulated
transcripts showed good concordance between oligonu-
cleotide array and RT-qPCR analyses (e.g. fold change of
adenosine deaminase at T30 -2.778 and -3.413, for oligo
and RT-qPCR analysis, respectively). Similarly, upregu-
lated transcripts showed good concordance, albeit with a
smaller fold-change in RT-qPCR analyses (e.g. LDC,
Table 1).
Drug-induced changes to the P. falciparum proteome
To further investigate the effect of the cyclohexylamine
perturbation on P. falciparum, global protein expression
analyses was also performed using 2D gel electrophoresis
(2D-GE). Similar to the transcriptome analyses, differen-B
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Table 1: Correlation of transcripts and proteins of the polyamine biosynthetic pathway following PfSpdSyn inhibition. 
Fold change (relative to control)
Annotation
PlasmoDB ID
Hours post invasion Oligos representing gene Oligonucleotide array RT-qPCR Proteomics
18 1 -2.304 -3.472 nd
Adenosine deaminase, putative
PF10_0289
25 1 -2.907 -5.495 nd
30 1 -2.778 -3.413 -3.030
18 1 -3.559 -4.651 nd
Purine nucleoside phosphorylase/uridine 
phosphorylase, putative
PFE0660c
25 1 -3.731 -5.882 -2.222
30 1 -3.367 -4.348 nd
18 1 -1.961 -3.115 nd
Phosphoethanolamine N-methyltransferase, putative
MAL13P1.214
25 1 -3.401 -5.495 nd
30 1 -3.774 -4.049 nd
18 2 -1.157 1.123 -1.185 nd
Spermidine synthase
PF11_0301
25 2 -1.038 1.300 -1.289 nd
30 2 -1.035 1.320 +1.087 ndB
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18 1 +1.324 -1.362 nd
Lysine decarboxylase, putative
PFD0285c
25 1 +2.426 +1.106 nd
30 1 +1.954 +1.591 nd
18 1 -1.300 nd -3.030
Ornithine aminotransferase, PFF0435w 25 1 +1.044 nd nd
30 1 +1.182 nd nd
18 1 -1.597 nd -2.857
S-adenosyl methionine synthethase,
PFI1090
25 1 -1.631 nd -2.222
30 1 -1.761 nd nd
18 1 1.347 nd
Eukaryotic translation initiation factor 3 subunit 10, 
putative
(endogenous control)
PFL0625c
25 1 1.210 endogenous 
control
nd
30 1 1.221 nd
The array and quantitative real-time PCR (RT-qPCR) datasets showed a high degree of concordance revealed by a Pearson correlation (r) of 0.88. Fold changes for transcripts and proteins are 
given at each time point. Differentially affected genes and their cognate proteins generally exhibited the same direction and level of regulation.
Table 1: Correlation of transcripts and proteins of the polyamine biosynthetic pathway following PfSpdSyn inhibition.  (Continued)Becker et al. BMC Genomics 2010, 11:235
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tial analyses were obtained by comparing drug-treated
proteome profiles of the parasites at the three time points
(18, 25 and 30 hpi) to the protein profile of untreated par-
asites at 18 hpi. Using PDQuest (Biorad), a total of 167
protein spots were successfully matched with high confi-
dence (CI ≥ 95%) across three replicate gels representing
the parasite's entire 18 hpi untreated proteome. Of these,
159, 155, and 149 spots were matched with high confi-
dence to corresponding 2D-GE spots representing the
parasite's drug-treated proteome at 18 hpi, 25 hpi, and 30
hpi respectively. Statistical analysis revealed a total of 38
differentially expressed proteins with at least a two-fold
change and a statistical significance of p = 0.05 (Student's
T-test). The identities of 21 of these were positively estab-
lished through MALDI-QTOF-MS and MS/MS (nine at
18 hpi, six at 25 hpi and six at 30 hpi) (Additional file 3:
Table S3). Four of these were found to be involved in the
polyamine/methionine biosynthetic pathway, namely
ornithine aminotransferase (PFF0435w), S-adenosylme-
thionine synthetase (PFI1090w), uridine phosphorylase,
putative (PFE0660c) and adenosine deaminase
(PF10_0289). It was not possible to establish the identities
of 17 of the 38 differentially expressed proteins, due to
their low abundance being beyond the detection limits of
the mass spectrometer used. However, the successful
identification using mass spectrometry of 21 out of the 38
differentially expressed proteins selected for character-
ization (i.e. a yield of 55%) compared well to previous 2D-
GE studies of Plasmodial proteins which displayed an
identification rate of approximately 30% [9,32].
Inhibition of SpdSyn in P. falciparum resulted in a gen-
eral downregulation in expressed proteins. Expression of
all but one (a putative pyruvate kinase (PFF1300w)) of the
21 differentially affected proteins identified was found to
be downregulated. Of these, six displayed a similar direc-
tion of differential expression with their corresponding
genes, even though the expression levels varied (Addi-
tional file 3: Table S3). For 14 downregulated proteins, no
significant change in underlying gene expression was
observed following treatment, while in the case of the
putative pyruvate kinase (PFF1300w), increased accumu-
lation of this protein was detected in contrast to a relative
reduction in underlying levels of mRNA. In previous
studies, moderately high correlation between mRNA and
protein abundance has been shown for P. falciparum,
varying in degree of correlation according to the para-
site's stage-specific development [33]. However, this
effect is not observed for all proteins and their encoding
genes, and it has been proposed that this discrepancy in
part reflects the contribution of more complex regulatory
processing involving post-transcriptional mechanisms
and/or protein peptide modification [33]. Thus, in the
case of the putative pyruvate kinase (PFF1300w) for
example, in-depth analysis to determine the modification
status of this sequence at the gene and protein level may
shed more light on the contrasting changes observed in
expression.
Selected metabolite profiling of cyclohexylamine-treated P. 
falciparum
Information regarding the effect of PfSpdSyn inhibition
on the polyamine profile of P. falciparum is still lacking.
To investigate polyamine perturbations resulting from
treatment of P. falciparum with cyclohexylamine,
selected metabolite profiling was performed on these
parasites. HPLC analyses of polyamines of both cyclohex-
ylamine-treated and untreated P. falciparum trophozoites
(25 hpi) revealed significant fluctuations in the polyamine
content of the parasites (Figure 2). A significant increase
(4-fold, p-value 0.004) in the PfSpdSyn substrate
putrescine was observed after inhibition. PfSpdSyn inhi-
bition also led to depletion in the levels of the down-
stream product metabolites, spermidine and spermine
(spermidine: ~2- fold decrease (p-value 0.056); spermine:
1.7-fold decrease (p-value 0.099)). Levels of the related
polyamine, cadaverine, were assessed to investigate
whether a compensatory increase in this metabolite
occurs due to induction of LDC transcripts. Levels
appeared to be increased but the change was not statisti-
cally significant.
Perturbation responses include polyamine and associated 
pathways
Differentially affected transcripts and proteins were ana-
lyzed in MADIBA [34,35] to ascertain which metabolic
pathways were affected by cyclohexylamine challenge. All
differentially regulated genes/proteins at each time point
were submitted as a cluster. Generally, gene clusters sub-
mitted for analyses following clustering are smaller than
either of the lists of differentially down- or upregulated
genes at each time point (ranging from 81 (upregulated at
30 hpi) to 285 (downregulated at 18 hpi)). Hence, larger
p - v a l u e s  w e r e  e x p e c t e d  f r o m  t h e  c o n t i n g e n c y  t e s t
(Fisher's exact test). Nonetheless, the polyamine biosyn-
thetic pathway ranked among the pathways most affected
(according to lowest p-value) by cyclohexylamine treat-
ment by analyzing the transcriptome data (p-values for
polyamine metabolism 0.214, 0.102 and 0.088 for T18, T25,
T30, respectively). This effect on the polyamine pathway
was confirmed for differentially expressed proteins
(0.028, 0.019 and 0.016 for T18, T25 and T30, respectively).
The lower p-values for differentially affected pathways
elucidated by proteomics analysis were expected since
the proteome coverage was not as extensive as the tran-
scriptome analysis (21 proteins vs. 4585 unique genes
interrogated) and therefore a smaller amount of proteins
were submitted to the contingency test (Additional file 3:
Table S3). Comparatively, the glycolytic pathway wasBecker et al. BMC Genomics 2010, 11:235
http://www.biomedcentral.com/1471-2164/11/235
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scored at 0.322 and 0.416 (T18 and T25, respectively) and
oxidative phosphorylation at 0.106, 0.012 and 0.035 (T18,
T25 and T30, respectively) within the transcriptome data-
set. For the proteome, the glycolytic score was 0.054 for
both T18 and T30, and not affected at T25.
Differentially affected transcripts and their cognate
proteins mapping to the polyamine biosynthetic pathway
included adenosine deaminase (maximal fold change -
2.907 (transcript) and -3.030 (protein) downregulated)
and uridine phosphorylase (fold change -3.731 (tran-
script) and -2.222 (protein) downregulated) (Table 1, Fig-
ure 3). Transcripts encoding LDC (fold change +2.426)
were also affected. Furthermore, genes acting in pathways
directly linked to the polyamine pathway were differen-
tially regulated. These included four transcripts (ribonu-
cleotide reductase small subunit, putative (PF10_0154),
inorganic pyrophosphatase, putative (PFC0710w), pro-
tein with aminophospholipid-transporting P-ATPase and
guanyl cyclase domains (MAL13P1.301) and thioredoxin
reductase (PFI1170c)) in the purine metabolic pathway
and five methyltransferases (phosphoethanolamine N-
methyltransferase, putative (MAL13P1.214), S-adenosyl-
methionine-dependent methyltransferase, putative
(PFE1115c), methyl transferase-like protein, putative
(PF13_0016), protein-L-isoaspartate O-methyltransferase
beta-aspartate methyltransferase, putative (PF14_0309)
and N6-adenine-specific methylase, putative
(MAL13P1.255)) (Figure 3). Additional significantly
affected proteins functioning in the polyamine biosyn-
thetic pathway included ornithine aminotransferase (fold
change -3.030 in the first time point) and S-adenosylme-
thionine synthetase (fold change -2.857 in the first time
point) (Figure 3, Table 1). Transcripts for the latter were
also downregulated but not to the extent of the 2-fold
cutoff (Table 1).
Data obtained in this study was compared to that from
two previous profiling experiments involving polyamine
biosynthetic inhibitors namely DFMO (ODC inhibitor;
[28]) and DFMO/MDL73811 (ODC/AdoMetDC inhibi-
tors respectively; [9]). A large degree of overlap was
observed for differentially expressed genes and proteins,
but effects specific to each treatment were also identified
Figure 2 Levels of selected polyamines following PfSpdSyn inhibition. Values represent the concentration of polyamine per 1010 cells, measured 
from two independent experiments performed in duplicate. Error bars are given as the standard error of the mean. Statistical significance is indicated 
by *** equivalent to 99% (p < 0.01) and * to 90% (p < 0.10) determined through a heteroscedastic Student t-test analysis.
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(Table 2). Indeed, 21 upregulated transcripts in the
PfSpdSyn inhibition dataset were also observed in the
PfAdoMetDC/ODC dataset (12.3% of the latter). More-
over, this number was increased to 60 for overlapping
downregulated genes (16% of the PfAdoMetDC/ODC
inhibition dataset). Six transcripts of the polyamine path-
way were affected in exactly the same manner, whether
PfSpdSyn was inhibited with cyclohexylamine (this study)
or whether the bifunctional PfAdoMetDC/ODC were co-
inhibited with DFMO/MDL73811 (unchanged: spermi-
dine synthase (PF11_0301); upregulated: LDC
(PFD0285c); and downregulated: uridine phosphorylase
(PFE0660c), adenosine deaminase (PF10_0289), S-adeno-
sylmethionine synthetase (PFI1090w) and adenosylho-
mocysteinase (PFE1050w) (Table 2)). Conversely,
transcripts differentially regulated amongst the three
treatments were OAT (PFF0435w, PfSpdSyn inhibition:
unchanged (with the exception of protein at 18 hpi), ODC
and PfAdoMetDC/ODC inhibition: upregulated), PfA-
doMetDC/ODC (PF10_0322, unaffected in PfSpdSyn
inhibition, down in PfAdoMetDC/ODC inhibition, not
determined in ODC inhibition) and hypoxanthine phos-
phoribosyltransferase (PF10_0121, unchanged in
PfSpdSyn and PfAdoMetDC/ODC inhibition but upregu-
lated by ODC inhibition).
Discussion
In this investigation, cyclohexylamine treatment of P. fal-
ciparum  parasites resulted in a perturbation-specific
response due to polyamine depletion (regulation of sper-
midine synthase, LDC, uridine phosphorylase, adenosine
deaminase, S-adenosylmethionine synthetase and adeno-
sylhomocysteinase) as well as an inhibitor-specific
response due to spermidine synthase inhibition on the
transcriptional level (regulation of OAT, PfAdoMetDC/
ODC and hypoxanthine phosphoribosyltransferase).
These responses will be discussed at the level of the spe-
cific polyamine biosynthetic enzymes in more detail.
LDC
In a previous investigation, inhibition of both decarboxy-
lase activities of the bifunctional PfAdoMetDC/ODC led
to the marked upregulation of LDC over a time course
[9]. PfSpdSyn inhibition also led to an increase in tran-
scripts encoding LDC, albeit only in one time point in
array analyses, and not to the extent of the two-fold cutoff
in RT-qPCR analyses. This upregulation of LDC is
Figure 3 Regulation of transcripts, proteins and metabolites of the polyamine biosynthetic pathway following cyclohexylamine inhibition. 
The relative expression (to untreated control samples) of each transcript and its encoding protein is indicated at each time point sampled. Increased/
decreased levels of selected metabolites are indicated. Additionally, regulation of transcripts in purine metabolism and various methyltransferases are 
indicated.
Uridine phosphorylase
Adenosine deaminase
Spermidine synthase cyclohexylamine
Adenosylmethionine 
decarboxylase Various methyltransferases
Adenosylhomocysteinase
Methionine synthase
S-adenosyl methionine synthetase
Purine metabolism
Arginine and proline metabolism
S-adenosyl methioninamine
L-methionine
Homocysteine S-adenosylhomocysteine
Adenosine
Ornithine decarboxylase
Ornithine
Putrescine
Spermidine
Methylthioadenosine
Methylthioinosine
Purine metabolism
Hypoxanthine
S-adenosylmethionine
Ornithine aminotransferase
Glutamate and proline metabolism PFE0660c
PF10_0289
PF11_0301
PFF0435w
PFF0435w
PFE0660c
PF10_0289
PFI1090
PFI1090
PF10_0322
PFE1050w
fold change >2
fold change 1.5-2
unchanged/not significant
fold change -1.5 to -2 
fold change > -2
TRANSCRIPT
PROTEIN
18 25 30
hours post invasion
PF10_0322
Lysine decarboxylase 
Cadaverine
Putrescine
PFD0285c
PFL1625w
MAL13P1.214
PFE1115c
PF13_0016
PF14_0309
MAL13P1.255
MAL13P1.301
PFC0710w
PF10_0154
PFI1170c
N N
N
NN
N N
N not determined
N PFE1050w N N
N N N PFL1625w
N N N
N N N
N N N PF10_0322
PF11_0301
PF10_0322
N N N PFD0285c
5 methylthio-ribose-1-phosphate
Metabolite
Metabolite
increased metabolite level
decreased metabolite level
SpermineB
e
c
k
e
r
 
e
t
 
a
l
.
 
B
M
C
 
G
e
n
o
m
i
c
s
 
2
0
1
0
,
 
1
1
:
2
3
5
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
1
6
4
/
1
1
/
2
3
5
P
a
g
e
 
1
0
 
o
f
 
1
6
Table 2: The regulation of transcripts and proteins of the polyamine pathway in three distinct inhibition experiments. 
Annotation PlasmoDB ID Cyclohexylamine
(PfSpdSyn inhibition)
(This work)
DFMO/MDL73811
(PfAdoMetDC/ODC inhibition)
[9]
DFMO (ODC 
inhibition)
[28]
Transcript Protein Transcript Protein Transcript
Ornithine aminotransferase PFF0435w ≈ ￿￿￿￿
S-adenosylmethionine decarboxylase-ornithine 
decarboxylase (PfAdoMetDC/ODC)
PF10_0322 ≈ nd ￿ nd nd
Hypoxanthine phosphoribosyltransferase PF10_0121 ≈ nd ≈ nd ￿
Uridine phosphorylase, putative PFE0660c ￿￿￿ nd nd
Adenosine deaminase, putative PF10_0289 ￿￿￿ nd nd
Spermidine synthase PF11_0301 ≈ nd ≈ nd nd
S-adenosylmethionine synthetase, putative PFI1090w ￿* ￿￿￿ nd
Adenosylhomocysteinase (S-adenosyl-L-
homocysteine hydrolase)
PFE1050w ￿* nd ￿ nd nd
Lysine decarboxylase, putative PFD0285c ￿ nd ￿ nd nd
* = fold change between -1.5 and -2 fold
￿ = downregulated
￿ = upregulated
≈ = unchanged
nd = not determined
A large degree of overlap was observed for the response to polyamine depletion, whether PfSpdSyn, PfAdoMetDC/ODC or ODC alone were inhibited. Also, effects specific to each inhibitor could 
be gauged.Becker et al. BMC Genomics 2010, 11:235
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r e g a r d e d  a s  a  s p e c i f i c  c o m p e n s a t o r y  r e s p o n s e  t o
polyamine metabolism perturbation resulting in
polyamine depletion. Lysine decarboxylation produces
cadaverine, a diamine and structural analogue of
putrescine, presumably to compensate for the lack of
other polyamines as has been shown in plants and par-
tially in Plasmodium [36,37].
Adenosine deaminase and uridine phosphorylase
As expected, downstream enzymes whose function is
dependent on the metabolism of polyamines, including
adenosine deaminase and uridine phosphorylase, were
downregulated upon perturbation of polyamine metabo-
lism on both transcript and protein levels. These were
also affected upon PfAdoMetDC/ODC co-inhibition [9].
Therefore, the decreased production of 5-methylthioade-
nosine, a substrate for adenosine deaminase, after
polyamine depletion [14], possibly resulted in a regula-
tory signal to decrease the production of this protein at
the transcriptional level. Consequently, this downregula-
tion may explain the observed decrease in 5-methylinos-
ine following PfAdoMetDC/ODC co-inhibition [14],
which manifests in the downregulation of the production
of uridine phosphorylase. Ultimately, the downregulation
of these proteins would result in the decreased produc-
tion of precursors for purine metabolism as well as meth-
ionine synthesis.
OAT
During the inhibition of ODC or the co-inhibition of both
decarboxylase activities of the bifunctional PfA-
doMetDC/ODC [9,28] an upregulation in both the tran-
script and protein for OAT was observed, potentially to
prevent toxic accumulation of ornithine when this
metabolite was not used for polyamine production. This
was clearly confirmed with a metabolomic analysis which
indicated the total depletion of putrescine levels due to
the abovementioned inhibition and a homeostatic main-
tenance of ornithine levels [9,38]. However, upon inhibi-
tion of PfSdpSyn, this compensatory increase in OAT
transcripts or protein was not observed, which corrobo-
rates its specific upregulation when ornithine decarboxy-
lation is prevented.
It would be predicted that inhibition of PfSpdSyn would
result in an increase in putrescine concentrations in the
parasite and a marked decrease in spermidine concentra-
tions. Metabolite analyses of P. falciparum confirmed that
inhibition of PfSpdSyn results in a substantial increase in
putrescine concentration. Moreover, a decrease was
observed in spermidine and spermine concentrations. P.
falciparum  lacks a spermine synthase activity but
PfSpdSyn has been shown to uniquely metabolize its
product, spermidine, to additionally provide spermine
(10% of its activity, [12]). The observation of a decrease in
spermine levels after PfSpdSyn inhibition with cyclohexy-
lamine therefore confirms this secondary activity of the
protein.
PfAdoMetDC/ODC
The co-inhibition of the bifunctional PfAdoMetDC/ODC
r e s u l t e d  i n  a  d o w n r e g u l a t i o n  o f  t h e  t r a n s c r i p t  f o r  t h i s
protein [9]. This effect was not mirrored by PfSpdSyn -
the transcript for this protein was not differentially
affected and, moreover, putrescine levels increased.
Therefore, it seems as if an increase in this metabolite (as
was observed for PfSpdSyn inhibition) does not trigger
the regulation of PfAdoMetDC/ODC.
Methionine recycling
Inhibition of PfSpdSyn resulted in a decrease in tran-
scripts for proteins involved in methionine recycling.
PfSpdSyn inhibition could presumably also have caused
an increase in the decarboxylated form of AdoMet as a
product of AdoMetDC. Decarboxylated AdoMet is exclu-
sively used in the synthesis of polyamines [1] and as such,
its homeostasis is controlled only by polyamine and
methionine metabolism. After co-inhibition of PfA-
doMetDC/ODC [14], it was shown that AdoMet levels
were homeostatically controlled in the parasite, presum-
ably to prevent a hypermethylated state. The mechanism
proposed for the homeostatic control of AdoMet levels in
Plasmodia is the downregulation of its synthesis, effec-
tively by downregulating the synthesis of AdoMet syn-
thetase [39]. This downregulation was also observed on
both transcript and protein levels in this study after
PfSpdSyn inhibition.
Three independent profiling investigations of different
polyamine biosynthesis inhibitors indicated highly repro-
ducible perturbation-specific results, as well as specific
effects related to the inhibitors used. These findings lend
support to the growing body of evidence that implicates a
role for transcriptional level control in the response of P.
falciparum  to drug perturbation. The findings further
highlight that this organism demonstrates an ability to
mount a compensatory response following drug pertur-
bation of the polyamine pathway. For P. falciparum, an
organism noted for it's adeptness to developing drug
resistance, such knowledge is critical to guiding the
future direction of drug development strategies seeking
to target the polyamine biosynthetic pathway. It is also
becoming clear that the phenomenon of directed tran-
scriptional level response to perturbation may occur in
select biological processes within the parasite, e.g. in the
case of antifolate inhibition such events are not observed
[40,41]. This suggests the presence of a highly complex
regulatory system which still remains to be fully eluci-
dated, where the dominant regulation may occur at the
transcriptional level for some genes, whereas for others itBecker et al. BMC Genomics 2010, 11:235
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may occur at the post-transcriptional and/or translational
level. Recent advances in microarray and mass spectrom-
etry technologies, which now enable simultaneous and
in-depth high-throughput analysis of such events, prom-
ise to provide greater insight into these phenomena.
Conclusions
In this investigation, the consequences of inhibiting
SpdSyn in P. falciparum were evaluated on several levels.
Unique polyamine biosynthetic effects, specific to the
inhibition of PfSpdSyn, were observed. These effects
stem from the specific polyamines perturbed; in this
instance the inhibition of the formation of spermidine
and spermine. By providing detailed analyses of the con-
sequences of PfSpdSyn inhibition, this work also contrib-
utes to efforts aiming to identify drug targets most suited
to chemotherapeutic intervention in this pathway.
Methods
Culturing and drug treatment
Culturing of parasites and drug treatment experiments
were conducted under aseptic conditions. P. falciparum
isolate 3D7 parasites were cultured in 75 cm2 flasks (Nal-
gene) in human erythrocytes (blood group A+) and RPMI
1640 medium supplemented with 25 mM HEPES,
0.0088% hypoxanthine, 40 ug/ml gentamycin (all Sigma)
and 0.5% Albumax (Invitrogen). Parasites were main-
tained in continuous culture in a 10 ml volume, and were
scaled up to 50 ml for drug treatments. The parasitemia
and morphological forms detected in the cultures were
determined and estimated by Giemsa (Fluka) stained
smears under 1000× light microscopy.
Prior to morphology studies and drug treatment, cul-
tures were synchronized with 5% D-sorbitol [42] for 5
min at 37°C to select for parasites in the ring stage. Sorbi-
tol treatment was repeated two days later. A morphologi-
cal analysis of the culture was performed in the presence
and absence of 2 mM cyclohexylamine (corresponding
IC99 value) in DMSO over a 48 h period. Smears of the
cultures were prepared every 6 h post drug treatment.
Fresh cultures were scaled up to 50 ml (5% hematocrit,
10% parasitemia), synchronized twice and treated with 2
mM cyclohexylamine at invasion (K. Lüersen, personal
communication). Fifteen milliliters of culture was har-
vested at late ring/early trophozoite (18 hpi), mid tropho-
zoite (25 hpi) and late trophozoite (30 hpi) stages. Similar
volumes were harvested from untreated P. falciparum
3D7 control cultures at the same time points. Parallel
d r u g  t r e a t m e n t s  w e r e  c o n d u c t e d ,  s e r v i n g  a s  b i o l o g i c a l
replicates.
RNA extraction
Erythrocytes from harvested cultures were pelleted,
washed once with 1× PBS to remove traces of culture
medium, and then frozen at -80°C until RNA extractions
were performed. RNA was extracted by the method
described by [28] and quantified using the Nanodrop
1000 spectrophotometer (Thermo Scientific). The integ-
rity was confirmed on an Agilent Bioanalyzer.
Universal Reference RNA pool (URR)
A reference pool of RNA from mixed-stage in vitro cul-
tures was constructed. Cultures were grown to high para-
sitemia, without synchronisation. Twenty-four (24)
cultures were harvested and flash-frozen in liquid nitro-
gen. RNA was extracted as described previously. Care
was taken to avoid bias towards any specific life cycle
stage. The percentage of spots on the microarray to
which the URR hybridized was determined in order to
gauge accurate expression ratios for as many spots as pos-
sible. Equal amounts of URR were labelled with either
Cy3 or Cy5 and hybridized to a microarray (as described
in next section). URR coverage was defined as the per-
centage of spots called "present" when local background-
subtracted intensity of a spot exceeded the average back-
ground intensity of all spots in that channel [31].
cDNA synthesis and array hybridization
A reference design was employed for array hybridisation,
utilising the URR pool described previously. All solvent-
control and drug-treated samples were hybridised to
Operon slides, along with the URR. For each time point
and each untreated/treated sample, three microarray
slides were processed, such that a total of eighteen slides
were processed in the study. Two independent cDNA
samples (biological replicates) were prepared for each
untreated and drug-treated sample at each time point.
One of the biological replicate cDNA samples were addi-
tionally hybridised to a third slide (representing the tech-
nical replicate). cDNA synthesis reactions of 12 μg each
were set up for each sample or reference RNA in a total of
50 μl. Prior to denaturation at 70°C for 10 min, 2 μl of
oligo d(T) primer (2 μg/μl) and 8 μl of random nanomer
primer (0.5 μg/μl) (both New England Biolabs) were
added. cDNA synthesis proceeded overnight at 42°C after
the addition of an aminoallyl-dNTP mix (Fermentas),
DTT, reaction buffer and 200 U of SuperScript III
Reverse Transcriptase (Invitrogen). RNA was hydrolyzed
by the addition of 10 μl each of 1 M NaOH and 0.5 M
EDTA solutions and incubated at 65°C for 10 min. Unin-
corporated aminoallyl dUTP was removed by purifica-
tion using the NucleoSpin Extract II Kit (Macherey-
Nagel). The eluted cDNA was quantified using a Nano-
drop spectrophotometer and similar quantities of test
and reference cDNA (typically 2 μg) were dried down to a
volume of 2.5 μl in a vacuum drier. Five microliters of a
0.2 M Na2CO3 buffer, pH 9.0, was added to the cDNA and
mixed well. Cy3 (sample) or Cy5 (reference) (2.5 μl) (GEBecker et al. BMC Genomics 2010, 11:235
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Healthcare) ester was added and the coupling allowed to
proceed for 2 h in the dark at room temperature. Uncou-
pled dyes were removed by purification with the RNeasy
Mini Kit (Qiagen). Probe labelling was estimated on a
Nanodrop. Similar amounts of labelled probe (typically
100 picomoles) were hybridized to the microarray slides.
Slides were prehybridized with a solution containing 5×
SSC (from 20× SSC: 3 M NaCl, 1.5 M sodium citrate, pH
7.0), 0.1% SDS and 0.1 mg/mL BSA, prewarmed to 42°C.
Prehybridization proceeded in 50 ml Falcon tubes, incu-
bated at 42°C for 45-60 min. Following prehybridization,
the slides were washed in three washes of 0.1× SSC before
centrifugation for 5 min at 200 × g. The combined Cy-
labelled probes (4 μl) were mixed with 36 μl of hybridiza-
t i o n  b u f f e r  ( O p e r o n )  f o r  a  t o t a l  v o l u m e  o f  4 0  μ l .  T h e
probes were denatured at 95°C for 5 min, and subse-
quently applied to the slide under Lifterslips (Erie Scien-
tific Company). The microarray slides were enclosed in
ArrayIt (Telechem International) hybridization chambers
and submersed in a heated water bath and incubated for
16-20 h at 42°C. The slides were successively washed in
low stringency (2× SSC, 0.5% SDS; heated to 42°C),
medium stringency (1× SSC) and high stringency (0.1×
SSC) wash buffers for 5 min each. Slides were then centri-
fuged (5 min, 200 × g). Scanning was performed with an
Axon GenePix 4000B scanner (Molecular Devices).
Microarray data analysis
GenePix results (gpr) files were generated using GenePix
6.0 (Molecular Devices) software, without normalization.
For clustering analyses, results files were normalized with
DNMAD (Diagnosis and Normalization for MicroArray
Data) [43] using print-tip loess. The normalized values
were subsequently downloaded and analyzed with the
Multiexperiment Viewer (MeV) in the TM4 software
suite [44]. Hierarchical Clustering (HCL, average linkage)
[45] was performed to estimate technical and biological
variation between samples and at which point cytostasis
most likely occurred for comparative purposes in down-
stream analyses. Intensity data for individual slides were
imported into LIMMA (linear models for microarray
data) in the R computing environment [46]. Pre- and
post-normalization diagnostic plots were performed
u s i n g  MA R RA Y .  D a t a  f r o m  e a c h  m i c r o a r r a y  s l i d e  w a s
normalized using print-tip loess. Data between microar-
rays was normalized using rquantile normalisation. Pear-
son correlations were computed in ExCel to estimate
variation between technical and biological replicates.
Spots excluded from slide correlations and normalisation
were those weighted by the limma script or flagged in the
Genepix results file (gpr). Additionally, spots termed
Alien, Empty, Null and Operon Use Only were excluded
from the correlation analyses. These spots were similarly
excluded for correlations between untreated and treated
samples at each time point following normalisation.
Results from biological and slide replicates within each of
t h e  t i m e  po i n ts  w e r e  c o l l a t e d ,  a n d  l i n e a r  m od e l s  w e r e
c o m p u t e d  t o  c o n t r a s t  g e n e  e x p r e s s i o n  b e t w e e n  t i m e
points. A two-fold change in gene expression was used as
cut-off, in conjunction with correction for false discovery
(false discovery rate (FDR) = 5%). Normalised data was
deposited in the Gene Expression Omnibus (GEO) data-
base, number GSE18075. Analysis of differentially
expressed genes was performed in MADIBA ([34] Micro
Array Data Interface for Biological Annotation [35]).
Quantitative Real-Time PCR
cDNA samples prepared for microarray analyses were
utilized for quantitative real-time PCR (RT-qPCR) valida-
tion of global expression analysis. Briefly, cDNA (with
500 nM of each primer and 1× Power SYBR Green PCR
Master Mix (Applied Biosystems)) was amplified in 96
well plates in an Applied Biosystems 7500 Real-Time PCR
cycler. Primers were designed using Primer3 Plus [47]
with the qPCR module activated. Primer sequences used
for polyamine as well as housekeeping genes are available
on request. Following enzyme activation at 95°C for 10
min, the cDNA was amplified for 40 cycles (95°C for 15 s,
60°C for 60 s). A melt curve was performed to ascertain
primer specificity. Relative expression was calculated
using Applied Biosystems Sequence Detection Software.
Protein extraction and two-dimensional electrophoresis
Parasites from harvested cultures were released from
erythrocytes by saponin lysis [48] and the resulting pellet
washed five times in ice-cold wash medium (RPMI 1640
medium supplemented with 25 mM HEPES ((4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid), 20 mM
sodium bicarbonate and 40 μg/ml gentamycin; all Sigma).
A pellet from a 15 ml culture was resuspended in 500 μl
lysis buffer (8 M urea, 2 M thiourea, 2% CHAPS (3-[(3-
Cholamidopropyl)dimethylammonio]propanesulfonic
a c i d ) ,  6 5  m M  d i t h i o t h r e i t o l  ( D TT)  ( a l l  S i gm a )  a n d  1 %
IPG buffer pH 3-10 (Amersham)). The sample was
freeze-thawed five times in liquid nitrogen and then soni-
cated on ice (Bandelin Sonopuls sonicator, at power level
65%) using five 10 sec bursts with 10 sec of cooling in
between. Care was taken to prevent warming of the sam-
ple, which introduces artifacts resulting from urea break-
down and protein carbamylation. The supernatant was
clarified by ultracentrifugation at 30 000 × g for 30 min at
4°C [49]. Protein concentration was assayed in duplicate
by the RCDC protein assay kit (BioRad) against a stan-
dard curve of bovine serum albumin (BSA, BioRad). Iso-
electric focusing (IEF) of total protein, 300 μg (analytical
gels) and 450 μg (preparative gels), was performed as
described by [9]. After IEF, gel strips were equilibrated
and cysteine residues reduced and subsequently alkylatedBecker et al. BMC Genomics 2010, 11:235
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by treatment with 1% DTT and 2.5% iodoacetamide
(Sigma) in equilibration buffer (50 mM Tris-HCl pH 8.8,
6 M urea, 30% glycerol, 2% SDS and bromophenol blue)
for 10 min each prior to second dimension analysis. Two-
dimensional electrophoresis (2DE) was subsequently per-
formed on 12.5% polyacrylamide gels at constant current
of 40 mA per gel for three hours on the Protean II Cell
system (BioRad). After 2DE, analytical gels were stained
with SyproRuby fluorescent stain (BioRad) and prepara-
tive gels with PageBlue Protein stain (Fermentas) accord-
ing to the suppliers' protocol. Gels were imaged with
Pharos FX imager (BioRad) and differential analysis per-
formed using PDQuest™ (V 8.0.1; BioRad) software on a
set of three independent gels per experimental condition.
Data comparison was carried out against the untreated
protein profile at 18 hpi. Spot intensity was normalized
using the "local regression" model to compensate for non-
expression-related variations in spot intensity. Images
were analyzed for quantitative differences, using two-fold
difference in expression with a t-test significance level of
95% applied.
Protein identification
In-gel digestion
Protein spots of interest were manually excised from
PageBlue stained gels. Low abundant proteins were
excised from more than one gel and gel plugs pooled to
increase protein yield for mass spectrometry (MS) analy-
sis. The number of gels that spots were excised from
depended on the intensity of the protein spot. Protein
spots were subjected to in-gel trypsin digestion and the
resulting peptide mixture was purified using Stage tips®
(Proxeon) prior to MS analysis.
Data acquisition
MS data was acquired using a Q-STAR Elite Q-TOF mass
spectrometer (Applied Biosystems) with either a MALDI
(matrix-assisted laser desorption ionization) or ESI (elec-
tron spray ionization) source depending on which source
was installed at the time of sample submission for MS
analysis.
MALDI-ionization
Samples were co-crystallized with 5 mg/ml α-cyano-4-
hydroxy cinnamic acid (CHCA, Brüker Daltonics) matrix
in 50% acetonitrile (ACN, Sigma), 0.1% trifluoro-acetic
acid (TFA, Sigma) and spectra acquired with a 337 nm
nitrogen laser operated at 20 Hz. Protein identification
was based on peptide mass fingerprint (PMF) and
sequencing data. The instrument was calibrated using
Brüker's peptide calibration standard II using peaks at
757.39 and 2093.08 m/z. PMF spectra were acquired in
positive ion mode using a range of 600-2500 m/z. MS/MS
data was obtained by collision induced dissociation
(CID), using argon as collision gas, from the 50 highest
parent ions in the corresponding PMF spectra.
ESI-ionisation
Samples were loaded in Proxeon NanoES capillaries and
ionized using IonSpray voltage of 900-1200 V. The instru-
ment was calibrated using Glu-Fibrinopeptide B (Sigma-
Aldrich) using fragment ions 246.15 and 1285.54 m/z.
PMF spectra were acquired in positive ion mode using a
range of 450 - 1500 m/z. MS/MS data obtained via Infor-
mation Dependent Acquisition (IDA) method where
doubly and triply charged parent ions were selected for
fragmentation by collision induced dissociation (CID),
using nitrogen as collision gas.
Data processing
Protein identification was performed by searching the
NCBI database using the Mascot search engine. The fol-
lowing parameters were used for database searches with
MALDI-QTOF PMF and sequencing data: monoisotopic
mass, peptide charge +1, 50 ppm mass accuracy, trypsin
as digesting enzyme with 1 missed cleavage allowed, car-
bamidomethylation of cysteine as a fixed modification,
oxidation of methionine as allowable variable modifica-
tion. For PMF data positive identifications equaled or
exceeded the minimum significant score of 70. By MS/
MS analysis, positive identifications required a minimum
of two unique peptides, with at least one peptide having a
significant ion score. Similar parameters were used to
search ESI-QTOF PMF and sequencing data with only
peptide charge set to +2 and +3. Exploratory analysis of
the differentially expressed proteins was performed in
MADIBA [34].
Polyamine metabolite analysis
Synchronized P. falciparum 3D7 cultures (two biological
replicates) were treated with 2 mM cyclohexylamine as
described for the transcriptome analyses. Parasites in
mid-trophozoite (25 hpi) stages were selected for
polyamine extraction. Triplicate samples of 20 ml para-
site culture (~20% parasitemia) were harvested, pelleted
by centrifugation at 2000 × g for 5 min (Boeco) and re-
suspended in 4× equivalent pellet volumes of PBS. These
wash steps were repeated four times in total. Subsequent
cell counting was performed accurately in quadruplicate
with a Neubauer Cell counting chamber (Weber).
PBS-washed cell pellets (1 ml) were subjected to pro-
tein precipitation using 5% (v/v) perchloric acid (PCA),
followed by vigorous vortexing, incubation at 4°C (over-
night) and subsequently precipitated by centrifugation at
16000 × g for 10 min at 4°C (Eppendorf). Polyamines
were detected using benzoylation as previously reported
with slight modification [50,51]. Five hundred μl of the
5% v/v PCA extract or 500 μl polyamine standard was
added to glass tubes with pure 5% PCA as blank. An
internal standard (1 nmol of 1,7-diaminoheptane (Sigma-
Aldrich)) was included in the P. falciparum extracts to
normalize for benzoylation efficiency. One ml 2.0 MBecker et al. BMC Genomics 2010, 11:235
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NaOH was added to each reaction, vortexed after which 5
μl of benzoyl chloride (Sigma-Aldrich) was added. The
reactions were incubated at 37°C for 30 min and stopped
by adding 1 ml chloroform (<99%) to allow the separation
of organic derivatized molecules. The tubes were centri-
fuged at 1500 × g (Medifuge) for 10 min, the aqueous
phases were removed to a new glass tube containing addi-
tional 1 ml chloroform for a second separation step as
above. The chloroform layers were pooled and evapo-
rated under N2 gas. One ml 0.1 M NaOH was added to
the white precipitate containing tubes and these were
incubated overnight at room temperature. Subsequently,
1 ml chloroform was added to the aqueous phases, centri-
fuged at 1500 × g for 10 min and the chloroform phases
evaporated under N2. Five hundred μl of 60% MeOH was
used to redissolve benzoylated products. The methanol
solutions were passed through 0.2 μm Minisart RC4 (Sar-
torius) HPLC-certified filters.
HPLC separation was performed using a WATERS Sys-
tem (Waters Corporation) with a 250 mm × 4.0 mm Luna
C18(2) 5 μm reverse-phase (RP) column (Phenomenex).
A Guard-Pak™ Precolumn steel housing (Waters Corpo-
ration) with μBondapak C18 HPLC pre-column inserts
(Waters Corporation) was connected in-line. Isocratic
solvent conditions were maintained using 60%
MeOH:ddH2O at flow rate of 1 ml/min. All solvents were
filtered using 0.2 μm cellulose acetate filters (Sartorius) in
Millipore™ housing system (Millipore) and degassed prior
to use. The HPLC pump system consisted of a WATERS
600 Controller (Waters Corporation) with a 600 Series
WATERS Pump (Waters Corporation) and a WATERS
712 WISP Autosampler. UV absorbance was measured at
229 nm using a WATERS 996 Photodiode array (Waters
Corporation). Peak integration was performed using the
Empower 2 Software Edition (2006, Waters Corporation)
with Apex™ Trac functionality.
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